BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24080146)

  • 1. A unique mouse model for investigating the properties of amyotrophic lateral sclerosis-associated protein TDP-43, by in utero electroporation.
    Akamatsu M; Takuma H; Yamashita T; Okada T; Keino-Masu K; Ishii K; Kwak S; Masu M; Tamaoka A
    Neurosci Res; 2013 Dec; 77(4):234-41. PubMed ID: 24080146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis.
    Ishihara T; Ariizumi Y; Shiga A; Kato T; Tan CF; Sato T; Miki Y; Yokoo M; Fujino T; Koyama A; Yokoseki A; Nishizawa M; Kakita A; Takahashi H; Onodera O
    Hum Mol Genet; 2013 Oct; 22(20):4136-47. PubMed ID: 23740936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
    JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin abolishes mutant TDP-43 induced excitability in a motoneuron-like cellular model of ALS.
    Dong H; Xu L; Wu L; Wang X; Duan W; Li H; Li C
    Neuroscience; 2014 Jul; 272():141-53. PubMed ID: 24785678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of TDP-43 inclusions linked to amyotrophic lateral sclerosis by a misfolding-specific intrabody with dual proteolytic signals.
    Tamaki Y; Shodai A; Morimura T; Hikiami R; Minamiyama S; Ayaki T; Tooyama I; Furukawa Y; Takahashi R; Urushitani M
    Sci Rep; 2018 Apr; 8(1):6030. PubMed ID: 29662239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
    Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
    Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered astrocytic expression of TDP-43 does not influence motor neuron survival.
    Haidet-Phillips AM; Gross SK; Williams T; Tuteja A; Sherman A; Ko M; Jeong YH; Wong PC; Maragakis NJ
    Exp Neurol; 2013 Dec; 250():250-9. PubMed ID: 24120466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.
    Geser F; Winton MJ; Kwong LK; Xu Y; Xie SX; Igaz LM; Garruto RM; Perl DP; Galasko D; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2008 Jan; 115(1):133-45. PubMed ID: 17713769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The molecular mechanisms of intracellular TDP-43 aggregates].
    Nonaka T; Arai T; Hasegawa M
    Brain Nerve; 2009 Nov; 61(11):1292-300. PubMed ID: 19938686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mislocalisation of TDP-43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex.
    Dyer MS; Reale LA; Lewis KE; Walker AK; Dickson TC; Woodhouse A; Blizzard CA
    J Neurochem; 2021 May; 157(4):1300-1315. PubMed ID: 33064315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
    Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
    Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast Progression in Amyotrophic Lateral Sclerosis Is Associated With Greater TDP-43 Burden in Spinal Cord.
    Cathcart SJ; Appel SH; Peterson LE; Greene EP; Powell SZ; Arumanayagam AS; Rivera AL; Cykowski MD
    J Neuropathol Exp Neurol; 2021 Sep; 80(8):754-763. PubMed ID: 34383907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology.
    Jara JH; Gautam M; Kocak N; Xie EF; Mao Q; Bigio EH; Ă–zdinler PH
    J Neuroinflammation; 2019 Oct; 16(1):196. PubMed ID: 31666087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin alleviates pathogenesis of a new Drosophila model of ALS-TDP.
    Cheng CW; Lin MJ; Shen CK
    J Neurogenet; 2015; 29(2-3):59-68. PubMed ID: 26219309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration--immunohistochemical and biochemical analyses of TDP-43.
    Kosaka T; Fu YJ; Shiga A; Ishidaira H; Tan CF; Tani T; Koike R; Onodera O; Nishizawa M; Kakita A; Takahashi H
    Neuropathology; 2012 Aug; 32(4):373-84. PubMed ID: 22098653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
    Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
    Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in subcellular localization of TDP-43 immunoreactivity in the anterior horns in sporadic amyotrophic lateral sclerosis.
    Sasaki S; Takeda T; Shibata N; Kobayashi M
    Neurosci Lett; 2010 Jul; 478(2):72-6. PubMed ID: 20447446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo.
    Kabashi E; Lin L; Tradewell ML; Dion PA; Bercier V; Bourgouin P; Rochefort D; Bel Hadj S; Durham HD; Vande Velde C; Rouleau GA; Drapeau P
    Hum Mol Genet; 2010 Feb; 19(4):671-83. PubMed ID: 19959528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that TDP-43 is not the major ubiquitinated target within the pathological inclusions of amyotrophic lateral sclerosis.
    Sanelli T; Xiao S; Horne P; Bilbao J; Zinman L; Robertson J
    J Neuropathol Exp Neurol; 2007 Dec; 66(12):1147-53. PubMed ID: 18090923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.